bufalin has been researched along with Carcinogenesis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 5 (71.43) | 2.80 |
Authors | Studies |
---|---|
Cao, Z; Chandrakesan, P; Chen, H; Chen, X; Ding, L; Du, J; Feng, H; Liao, Z; Lu, Q; Qu, D; Weygant, N; Yang, Y | 1 |
Huang, CJ; Meng, ZQ; Qian, L; Wang, D; Xie, L; Zhang, CY; Zhao, YK; Zhu, Y; Zhuang, L | 1 |
Akhenbekova, A; Farooqi, AA; Ibekenov, O; Kapanova, G; Rakhmetova, VS; Tashenova, G; Tulebayeva, A; Turgambayeva, A; Xu, B | 1 |
Cheng, AS; Feng, H; Gao, Y; Huang, L; Jiang, Y; Le, F; Li, M; Sun, X; Yu, DY; Yu, Z; Zhang, X; Zheng, C; Zhou, Z; Zhu, X; Zhuo, Y | 1 |
Chen, Y; Deng, M; Han, Q; Liu, B; Lv, F; Song, J; Sui, D; Wang, S; Wang, X; Yang, C; Zhang, Y; Zhao, X; Zou, D | 1 |
Cheng, AS; Feng, H; Gao, Y; Huang, L; Jiang, Y; Le, F; Li, M; Sun, X; Yu, Z; Zhang, X; Zheng, C; Zhou, Z; Zhu, X; Zhuo, Y | 1 |
Gong, P; Li, Y; Liu, X; Tian, X | 1 |
1 review(s) available for bufalin and Carcinogenesis
Article | Year |
---|---|
Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs.
Topics: Animals; Apoptosis; beta Catenin; Bufanolides; Carcinogenesis; Cell Line, Tumor; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Microenvironment | 2023 |
6 other study(ies) available for bufalin and Carcinogenesis
Article | Year |
---|---|
Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis.
Topics: Cadherins; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells | 2022 |
Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 Axis.
Topics: Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Lipogenesis; Liver Neoplasms; Sodium-Potassium-Exchanging ATPase; Sterol Regulatory Element Binding Protein 1 | 2023 |
Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
Topics: Animals; beta Catenin; Bufanolides; Carcinogenesis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Glycogen Synthase Kinase 3 beta; Hepatitis B virus; Liver Neoplasms; Mice, Nude; Mice, Transgenic; Models, Biological; Phosphorylation; Proteolysis; Receptors, Androgen; Signal Transduction; Sorafenib; Trans-Activators; Viral Regulatory and Accessory Proteins | 2020 |
Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Calcium Signaling; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mice; NFATC Transcription Factors; Proto-Oncogene Proteins c-myc; Signal Transduction; Xenograft Model Antitumor Assays | 2021 |
Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase.
Topics: Animals; beta Catenin; Bufanolides; Carcinogenesis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Female; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Mice; Mice, Nude; Signal Transduction; T Cell Transcription Factor 1; Xenograft Model Antitumor Assays | 2018 |
Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways.
Topics: Animals; Breast Neoplasms; Bufanolides; Carcinogenesis; Cell Death; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Pore Complex Proteins; Poly (ADP-Ribose) Polymerase-1; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction | 2018 |